SPY382.88-1.36 -0.35%
DIA309.97-1.90 -0.61%
IXIC13,543.06+12.15 0.09%

Baird Maintains Outperform on Sarepta Therapeutics, Raises Price Target to $192

Baird maintains Sarepta Therapeutics (NASDAQ:SRPT) with a Outperform and raises the price target from $181 to $192.

Benzinga · 12/20/2019 14:44

Baird maintains Sarepta Therapeutics (NASDAQ:SRPT) with a Outperform and raises the price target from $181 to $192.